AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Scope & Guideline
Leading the Charge in Respiratory Cell Research
Introduction
Aims and Scopes
- Cellular Mechanisms in Lung Disease:
Research articles often explore the cellular mechanisms involved in various lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. This includes studies on cellular signaling pathways, immune responses, and cellular interactions. - Molecular Pathways and Therapeutics:
The journal highlights studies that investigate molecular pathways involved in lung disease progression and resolution, as well as potential therapeutic targets for intervention. - Respiratory Infections and Inflammation:
A significant focus is placed on understanding the impact of respiratory infections (such as COVID-19) on lung health, including the inflammatory responses and potential long-term effects on lung function. - Stem Cell and Regenerative Medicine:
Research on stem cell biology, especially concerning lung repair and regeneration, is a core area, with studies exploring the roles of various stem cell types in the maintenance of lung homeostasis. - Environmental Influences on Lung Health:
The journal publishes studies examining the effects of environmental factors, such as tobacco smoke, air pollution, and microbial exposure, on lung biology and disease. - Translational Research:
There is a strong emphasis on translational research that bridges the gap between laboratory findings and clinical applications, aiming to improve therapeutic strategies for lung diseases.
Trending and Emerging
- Single-Cell Analysis Techniques:
There is a notable increase in studies utilizing single-cell RNA sequencing and other single-cell technologies to dissect the cellular heterogeneity within the lung, particularly in the context of diseases like asthma and pulmonary fibrosis. - Role of the Microbiome:
Emerging research examines the role of the lung microbiome and its interactions with host immunity, indicating a trend towards understanding how microbial communities influence lung health and disease. - Immunotherapy and Precision Medicine:
The journal is witnessing a rise in articles focused on immunotherapy and precision medicine approaches for treating respiratory diseases, reflecting a broader trend towards personalized medicine. - Long COVID and Post-Acute Sequelae:
Research addressing the long-term effects of COVID-19, including post-acute sequelae, has surged, highlighting the need to understand the mechanisms and impacts of this emerging health crisis. - Metabolic Pathways in Lung Disease:
An increasing number of studies are focusing on the metabolic pathways involved in lung diseases, linking metabolic dysregulation to disease mechanisms and potential therapeutic targets.
Declining or Waning
- Basic Mechanistic Studies:
There appears to be a waning interest in purely basic mechanistic studies without clear translational implications. Researchers are increasingly seeking to connect their findings to clinical applications. - Single-Agent Therapeutic Approaches:
The focus on single-agent therapeutic approaches is declining as there is a growing recognition of the complexity of lung diseases, prompting a shift towards combination therapies and multi-target strategies. - Traditional In Vivo Models:
There is a decreasing emphasis on traditional animal models for studying lung diseases, as researchers explore more sophisticated models, including human organoids and in vitro systems that better mimic human physiology. - Chronic Inflammation Studies:
While chronic inflammation remains a key area of interest, the frequency of studies solely focused on chronic inflammation markers without integrating them into broader disease mechanisms has decreased.
Similar Journals
RESPIRATORY MEDICINE
Innovating Solutions for Respiratory ChallengesRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
LUNG
Championing excellence in respiratory research and education.LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.
RESPIRATION
Publishing Insights that Shape Respiratory MedicineRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
MOLECULAR AND CELLULAR BIOCHEMISTRY
Fostering Innovation in Cellular BiochemistryMOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.
Tuberculosis and Respiratory Diseases
Connecting researchers in the fight against tuberculosis.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
RESPIROLOGY
Fostering Excellence in Pulmonary StudiesRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Turkish Thoracic Journal
Elevating respiratory medicine with open-access discoveries.Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.
Jornal Brasileiro de Pneumologia
Fostering collaboration in the pursuit of better lung health.Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.
Pulmonary Medicine
Championing Open Access for Global Health SolutionsPulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.
Thoracic Research and Practice
Empowering Respiratory Medicine with Open Access InsightsThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.